Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
head pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of headache in a 61-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (Patient had Shingles on head). Previously administered products included varicella zoster vaccine and Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In APR-2025, 7 years after receiving Shingrix, the patient experienced headache (Verbatim: head pain). The outcome of the headache was not resolved. It was unknown if the reporter considered the headache to be related to Shingrix. It was unknown if the company considered the headache to be related to Shingrix. Additional Information: GSK Receipt Date: 08-APR-2025 Patient stated that after having Shingles, on head, they received the old shingles vaccine, then had two-part Shingrix Vaccine approximately 7 years ago. Patient was experiencing head pain for the second day, similar to that of the early days leading up to when they first had Shingles. Also asked if they can take the Shingrix vaccine again.
Medical History/Concurrent Conditions: Shingles (Patient had Shingles on head)